Alexey V. Danilov - Department of Hematology and Oncology, Tufts Medical Center

基本信息

浏览量：62

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 353 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Impact of Chronic Lymphocytic Leukemia Comorbidity Index in a Young Population: a Real-World Evidence Study of a National Gulf Region Cohort

Salem H. Alshemmari, Ahmad AlSarraf,Andy Kaempf,Alexey V. Danilov

BMC cancerno. 1 (2024)

引用0浏览0WOS引用

CLL-638 Latest Results from an Ongoing Firstin-Human Phase 1a/b Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory CLL and Other B-Cell Malignancies

Kim Linton, Graham P. Collins, Francesco Forconi, Nirav N. Shah, Karan Dixit, Talha Munir,Zulfa Omer,Dima El-Sharkawi,Jeanette Doorduijn,Alvaro Alencar,Pam McKay,John Riches,Mary Gleeson,David Lewis,Allison Winter, Sarah Injac,Ted Shih,Srinand Nandakumar,May Tan,Ganesh Cherala,Erin Meredith,Alexey Danilov

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

T-bet Suppresses Proliferation of Malignant B Cells in Chronic Lymphocytic Leukemia

BLOOD（2024）

引用0浏览0WOS引用

Outpatient Administration of Brexucabtagene Autoleucel (Brexu-Cel) for Acute Lymphoblastic Leukemia (ALL) and Mantle Cell Lymphoma (MCL) is Safe and Feasible

Tamer Othman,John H. Baird, Yan Wang, Stacy Pak, Ibrahim Aldoss,Ji-Lian Cai,Alexey Danilov,Tycel J. Phillips, Vaibhav Agrawal,Karamjeet S Sandhu,Matthew Mei, Paul B. Koller,Joycelynne Michelle Palmer, Stephen J. Forman,Lihua E. Budde,Ahmed Aribi

Bloodno. Supplement 1 (2024): 2278-2278

引用0浏览0引用

Benefit of Rituximab Maintenance after First-Line Bendamustine-Rituximab in Mantle Cell Lymphoma

Yucai Wang, Melissa C. Larson,Anita Kumar, Brian T. Hill,David Alan Bond,Brad S. Kahl,Alexey Valeryevich Danilov,Reid Merryman,Natalie Sophia Grover,Aung M. Tun, Sabarish Ram Ayyappan,Georgios Pongas,Craig Anthony Portell,Javier Munoz,Patrick Michael Reagan, Muhamad Alhaj Moustafa,Priyanka Avinash Pophali,Irl Brian Greenwell,Jonathon Brett Cohen,Peter Martin

Journal of Clinical Oncologyno. 16_suppl (2024): 7006-7006

引用0浏览0引用

Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults with Non-Hodgkin Lymphoma

Max J. Gordon,Zhigang Duan,Hui Zhao,Loretta Nastoupil,Swaminathan Iyer,Alessandra Ferrajoli,Alexey V. Danilov,Sharon H. Giordano

JCO Clinical Cancer Informatics（2024）

引用0浏览0WOS引用

Bruton Tyrosine Kinase Degraders in B-Cell Malignancies

Tiana Huynh,Sonia Rodriguez-Rodriguez,Alexey V. Danilov

Molecular Cancer Therapeuticsno. 5 (2024): 619-626

引用0浏览0WOS引用

Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort

Juan Pablo Alderuccio,Jahanzaib Khwaja,Sunwoo Han, Paola Ghione, Imran A. Nizamuddin,Aditi Saha, Ning Dong,Yucai Wang, Hua-Jay J Cherng,Seda S. Tolu,Nina Wagner-Johnston, Adam J. Olszewski, Natalie Grover, Jean L. Koff,Amrita Desai, Praveen Ramakrishnan Geethakumari, Tamara K Moyo, Jose Sandoval-Sus, Narendranath Epperla,Danielle S Wallace, Manali Kamdar,Alexey Danilov,Han W. Tun,Javier Munoz,Mayur S. Narkhede,Joanna M. Rhodes,Anca Prica,Andrea Kuhnl, Adrian Maraj, Jessica Okosun,Jeffery Smith,Wendy Osborne, Victoria Calvert,Dima el-Sharkawi, Ammar Hilali, Graham P. Collins,Kim Linton, Nagah Elmusharaf,Anna Santarsieri, Farheen Karim,Thomas Ollila, Sarah Monick, Iris Margalit Trutzer,Nilanjan Ghosh,Jones Can,Amy Ayers, Jacopo Calabrese De Feo, John Sharp,Rachel Treitman,Avyakta Kallam, Izel Okcu, Vismay Deshani, Firas Baidoun,Chathuri Abeyakoon, William Hann,Aisling Barrett, Brad Kahl,Julio C. Chavez, Kate Cwynarski

Bloodno. Supplement 1 (2024): 571-571

引用0浏览0引用

A Phase 1 Study of the CDK9 Inhibitor Voruciclib in Relapsed/refractory Acute Myeloid Leukemia and B-cell Malignancies

Matthew S. Davids, Danielle M. Brander,Yesid Alvarado-Valero,Catherine S. Diefenbach,Daniel N. Egan,Shira N. Dinner,Nathalie Javidi-Sharifi,Monzr M. Al Malki,Kebede H. Begna, Vijaya Raj Bhatt,Sameem Abedin,Rachel J. Cook, Mary C. Collins, Carly Roleder, Edward C. Dominguez, Prabhu Rajagopalan, Sandra E. Wiley,Richard G. Ghalie,Alexey V. Danilov

Blood Advances (2024)

引用0浏览0引用

Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with De Novo Mantle Cell Lymphoma (MCL)

Paolo Lopedote,Geoffrey Shouse,Alexandra Muir, Carly Rolender,Peter Sportelli,Hari Miskin,Lu Chen,Tycel Phillips,Alexey Danilov

Bloodno. Supplement 1 (2024): 1633-1633

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn